Crosstalk Between Lncrnas in the Apoptotic Pathway and Therapeutic Targets in Cancer Publisher Pubmed



Ebrahimi N¹ ; Parkhideh S² ; Samizade S³ ; Esfahani AN³ ; Samsami S⁴ ; Yazdani E^{5, 6} ; Adelian S⁷ ; Chaleshtori SR⁸ ; Shahamiri K⁷ ; Ahmadi A⁹ ; Aref AR¹⁰
Source: Cytokine and Growth Factor Reviews Published:2022

Abstract

The assertion that a significant portion of the mammalian genome has not been translated and that non-coding RNA accounts for over half of polyadenylate RNA have received much attention. In recent years, increasing evidence proposes non-coding RNAs (ncRNAs) as new regulators of various cellular processes, including cancer progression and nerve damage. Apoptosis is a type of programmed cell death critical for homeostasis and tissue development. Cancer cells often have inhibited apoptotic pathways. It has recently been demonstrated that up/down-regulation of various lncRNAs in certain types of tumors shapes cancer cells' response to apoptotic stimuli. This review discusses the most recent studies on lncRNAs and apoptosis in healthy and cancer cells. In addition, the role of lncRNAs as novel targets for cancer therapy is reviewed here. Finally, since it has been shown that lncRNA expression is associated with specific types of cancer, the potential for using lncRNAs as biomarkers is also discussed. © 2022 Elsevier Ltd